Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model

Abstract

DC-based immunotherapy may not only be successfully combined with gemcitabine for the treatment of advanced pancreatic carcinoma, but may also be effective in preventing local recurrence or metastatisation in tumour-free patients.